CAD 0.01
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 5.12 Million CAD | 17.29% |
2022 | 7.7 Million CAD | -8.67% |
2021 | 8.44 Million CAD | -55.38% |
2020 | 18.91 Million CAD | 23.92% |
2019 | 15.26 Million CAD | 67.34% |
2018 | 9.12 Million CAD | 251.18% |
2017 | 2.59 Million CAD | -29.31% |
2016 | 3.67 Million CAD | 8897.33% |
2015 | 40.84 Thousand CAD | 0.0% |
2013 | 84.96 Thousand CAD | -44.9% |
2012 | 154.21 Thousand CAD | -72.84% |
2011 | 567.77 Thousand CAD | 273.11% |
2010 | 152.17 Thousand CAD | 147.52% |
2009 | 61.48 Thousand CAD | 89.95% |
2008 | 32.36 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 1.36 Million CAD | 6.57% |
2024 Q2 | 878.1 Thousand CAD | -47.63% |
2024 Q1 | 1.67 Million CAD | -56.85% |
2023 FY | 9.04 Million CAD | 17.29% |
2023 Q1 | 1.99 Million CAD | 21.93% |
2023 Q2 | 1.81 Million CAD | -9.3% |
2023 Q3 | 1.34 Million CAD | -25.88% |
2023 Q4 | 3.88 Million CAD | 189.13% |
2022 Q1 | 1.58 Million CAD | 29.3% |
2022 FY | 7.7 Million CAD | -8.67% |
2022 Q3 | 2.3 Million CAD | 6.09% |
2022 Q4 | 1.63 Million CAD | -28.98% |
2022 Q2 | 2.17 Million CAD | 37.22% |
2021 Q4 | 1.22 Million CAD | -29.0% |
2021 Q3 | 1.72 Million CAD | -35.68% |
2021 FY | 8.44 Million CAD | -55.38% |
2021 Q2 | 2.68 Million CAD | -4.19% |
2021 Q1 | 2.8 Million CAD | -38.75% |
2020 FY | 18.91 Million CAD | 23.92% |
2020 Q1 | 4.95 Million CAD | 45.46% |
2020 Q2 | 4.73 Million CAD | -4.5% |
2020 Q3 | 4.65 Million CAD | -1.75% |
2020 Q4 | 4.57 Million CAD | -1.63% |
2019 Q2 | 3.48 Million CAD | -22.78% |
2019 Q4 | 3.4 Million CAD | -19.64% |
2019 FY | 15.26 Million CAD | 67.34% |
2019 Q1 | 4.51 Million CAD | 25.11% |
2019 Q3 | 4.24 Million CAD | 21.7% |
2018 Q1 | 1.61 Million CAD | -13.76% |
2018 FY | 9.12 Million CAD | 251.18% |
2018 Q4 | 3.6 Million CAD | 106.81% |
2018 Q3 | 1.74 Million CAD | -19.04% |
2018 Q2 | 2.15 Million CAD | 33.14% |
2017 Q1 | 113.29 Thousand CAD | -94.03% |
2017 Q4 | 1.87 Million CAD | 243.62% |
2017 FY | 2.59 Million CAD | -29.31% |
2017 Q3 | 545.98 Thousand CAD | 128.36% |
2017 Q2 | 239.09 Thousand CAD | 111.04% |
2016 Q2 | 722.81 Thousand CAD | 284.44% |
2016 Q1 | 188.01 Thousand CAD | 385.89% |
2016 FY | 3.67 Million CAD | 8897.33% |
2016 Q4 | 1.89 Million CAD | 721.84% |
2016 Q3 | 230.75 Thousand CAD | -68.08% |
2015 Q4 | 38.69 Thousand CAD | -33.32% |
2015 FY | 40.84 Thousand CAD | 0.0% |
2015 Q3 | 58.03 Thousand CAD | 166.91% |
2015 Q2 | 21.74 Thousand CAD | 151.36% |
2015 Q1 | 8650.00 CAD | -80.86% |
2014 Q3 | 16.45 Thousand CAD | -43.13% |
2014 Q4 | 45.19 Thousand CAD | 174.57% |
2014 Q1 | 16.61 Thousand CAD | 42.09% |
2014 Q2 | 28.94 Thousand CAD | 74.21% |
2013 Q3 | 27.71 Thousand CAD | -52.67% |
2013 Q4 | 11.69 Thousand CAD | -57.82% |
2013 FY | 84.96 Thousand CAD | -44.9% |
2013 Q1 | 39.59 Thousand CAD | 60.95% |
2013 Q2 | 58.56 Thousand CAD | 47.92% |
2012 Q4 | 24.59 Thousand CAD | -21.8% |
2012 Q1 | 52.57 Thousand CAD | -49.32% |
2012 Q2 | 188.59 Thousand CAD | 258.74% |
2012 Q3 | 31.45 Thousand CAD | -83.32% |
2012 FY | 154.21 Thousand CAD | -72.84% |
2011 Q2 | 97.04 Thousand CAD | 168.73% |
2011 Q4 | 103.74 Thousand CAD | -53.45% |
2011 Q3 | 222.87 Thousand CAD | 129.67% |
2011 FY | 567.77 Thousand CAD | 273.11% |
2011 Q1 | 36.11 Thousand CAD | 340.23% |
2010 Q2 | 23.54 Thousand CAD | 12.65% |
2010 FY | 152.17 Thousand CAD | 147.52% |
2010 Q4 | 8203.00 CAD | -24.18% |
2010 Q3 | 10.81 Thousand CAD | -54.05% |
2010 Q1 | 20.9 Thousand CAD | 246.69% |
2009 Q1 | 17.5 Thousand CAD | 0.0% |
2009 Q4 | 6029.00 CAD | -45.2% |
2009 Q3 | 11 Thousand CAD | 0.0% |
2009 FY | 61.48 Thousand CAD | 89.95% |
2008 FY | 32.36 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | -3042.066% |
Ayurcann Holdings Corp. | 11.71 Million CAD | 56.255% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -5985.18% |
The BC Bud Corporation | 1.28 Million CAD | -299.479% |
BioNxt Solutions Inc. | 6.73 Million CAD | 23.953% |
CordovaCann Corp. | 3.86 Million CAD | -32.724% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | -19.66% |
Captor Capital Corp. | 16.28 Million CAD | 68.523% |
City View Green Holdings Inc. | 705.7 Thousand CAD | -626.254% |
1CM Inc. | 7.3 Million CAD | 29.867% |
Global Hemp Group Inc. | 551.7 Thousand CAD | -828.977% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -6.607% |
IM Cannabis Corp. | 22.63 Million CAD | 77.36% |
Lobe Sciences Ltd. | 4.13 Million CAD | -24.031% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | -1206.74% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -8442.072% |
Nextleaf Solutions Ltd. | 1.76 Million CAD | -189.888% |
Ovation Science Inc. | 54.1 Thousand CAD | -9373.647% |
Pharmadrug Inc. | 1.33 Million CAD | -283.91% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | -292.616% |
RAMM Pharma Corp. | 7.48 Million CAD | 31.484% |
RIV Capital Inc. | 21.1 Million CAD | 75.712% |
Revive Therapeutics Ltd. | 3.28 Million CAD | -55.986% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | 86.427% |
SLANG Worldwide Inc. | 24.6 Million CAD | 79.171% |
Red Light Holland Corp. | 2.02 Million CAD | -153.666% |
Top Strike Resources Corp. | 3.63 Million CAD | -41.123% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 1761.763% |
Adastra Holdings Ltd. | 9.36 Million CAD | 45.247% |